Tianzhihang: The audit and evaluation work for the matter of acquiring assets through share issuance is being advanced.

Tianzhihang announced that the company plans to issue shares to acquire 62% equity of Shanghai MicroPort Orthopedics Medical Technology Co., Ltd. and raise supporting funds. Upon completion of the transaction, the target company will become a controlled subsidiary. This transaction is expected to constitute a major asset restructuring and a related-party transaction, but will not constitute a restructuring listing. The company's shares will be suspended from July 16, 2026, and resume trading at market open on July 30. As of now, the audit, valuation and other work involved in this transaction are progressing in an orderly manner. The transaction valuation and price have not yet been determined, and the procedures of deliberation by the company's board of directors and shareholders' meeting, review by the Shanghai Stock Exchange, and registration by the CSRC still need to be fulfilled. Whether approval will be obtained remains uncertain.